Latest ViroPharma Stories
VIENNA and PHILADELPHIA, January 29, 2015 /PRNewswire/ -- Charles Rowland joins Supervisory Board Dr Steven Gelone
PHILADELPHIA, Aug. 13, 2014 /PRNewswire/ -- Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank.
Company will draw on leaders' expertise in rare diseases, R&D and commercialization as it moves to complete development of its lead program in inherited blindness PHILADELPHIA, June
EXTON, Pennsylvania, February 25, 2014 /PRNewswire/ -- ViroPharma Incorporated today announced the results of its tender offer (the "Convertible Notes Tender Offer") pursuant
EXTON, Pennsylvania, January 24, 2014 /PRNewswire/ -- ViroPharma, Inc.
DUBLIN, January 24, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces the successful completion of the tender offer for all of the outstanding shares of
DUBLIN, January 15, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has waived the Office of Fair Trading (OFT) approval condition to the announced
DUBLIN, January 10, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has extended the expiration of its previously announced tender offer by a